Literature DB >> 30370137

Is Clostridium difficile the new bugaboo after cardiac surgery?

Simona Silvetti1, Giovanni Landoni2.   

Abstract

Entities:  

Year:  2018        PMID： 30370137      PMCID： PMC6186595          DOI： 10.21037/jtd.2018.08.99

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

Review 1.  Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis.

Authors:  Hoonmo L Koo; Diana C Koo; Daniel M Musher; Herbert L DuPont
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

2.  Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.

Authors:  Kevin A Brown; Nagham Khanafer; Nick Daneman; David N Fisman
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

3.  Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens.

Authors:  J E Conte; S N Cohen; B B Roe; R M Elashoff
Journal:  Ann Intern Med       Date:  1972-06       Impact factor: 25.391

Review 4.  Does duration of perioperative antibiotic prophylaxis matter in cardiac surgery? A systematic review and meta-analysis.

Authors:  Dominik Mertz; Jennie Johnstone; Mark Loeb
Journal:  Ann Surg       Date:  2011-07       Impact factor: 12.969

5.  Effect of extended perioperative antibiotic prophylaxis on intravascular catheter colonization and infection in cardiothoracic surgery patients.

Authors:  J A T Sandoe; B Kumar; B Stoddart; R Milton; J Dave; U R Nair; M H Wilcox
Journal:  J Antimicrob Chemother       Date:  2003-10-16       Impact factor: 5.790

6.  Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth.

Authors:  Hans Strid; Magnus Simrén; Per-Ove Stotzer; Gisela Ringström; Hasse Abrahamsson; Einar S Björnsson
Journal:  Digestion       Date:  2003       Impact factor: 3.216

7.  The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.

Authors:  Judith A O'Brien; Betsy J Lahue; J Jaime Caro; David M Davidson
Journal:  Infect Control Hosp Epidemiol       Date:  2007-10-03       Impact factor: 3.254

Review 8.  Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.

Authors:  Stuart Johnson
Journal:  J Infect       Date:  2009-04-05       Impact factor: 6.072

Review 9.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

10.  Analysis of Clostridium difficile infections after cardiac surgery: epidemiologic and economic implications from national data.

Authors:  Andrew Flagg; Colleen G Koch; Nicholas Schiltz; Aiswarya Chandran Pillai; Steven M Gordon; Gösta B Pettersson; Edward G Soltesz
Journal:  J Thorac Cardiovasc Surg       Date:  2014-04-13       Impact factor: 5.209
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.